RegeneRx Biopharmaceuticals, Inc.
USD0.00
+0.00 (+0.00%)
CEO
J. J. Finkelstein
IPO Date
2003-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.16
Market Cap
$0.00B
Volume
0.00M
| -1387.7 |
| 31 Dec 2020 | FY | 93.6% | -1984.1% | 53.9% | -276.0% | -0.36 | 1.20 | -4246.8 |
| 31 Dec 2019 | FY | 99.9% | -1829.0% | 60.0% | -197.3% | -0.31 | 2.81 | -1306.0 |
| 31 Dec 2018 | FY | 99.9% | -2862.2% | 90.1% | -709.5% | -0.02 | 0.87 | -938.4 |
| 31 Dec 2017 | FY | 94.6% | 505.7% | -7.0% | 126.2% | -0.15 | 0.10 | 6375.6 |
| 31 Dec 2016 | FY | 99.7% | 245.6% | -3.8% | 26.6% | -0.13 | 1.29 | 14788.2 |
| 31 Dec 2015 | FY | 99.7% | -8694.6% | 78.2% | -1471.2% | -0.10 | 0.95 | -847.7 |
| 31 Dec 2014 | FY | 0.0% | 0.0% | 160.9% | -290.1% | -0.33 | 2.27 | -487.2 |
| 31 Dec 2013 | FY | 99.4% | -2275.8% | 41.4% | -1570.3% | -0.27 | 0.05 | -651.7 |
| -1274.9 |
| 30 Sept 2022 | Q3 | 100.0% | -1907.2% | 11.7% | -63.0% | -0.44 | 1.05 | -1372.7 |
| 30 Jun 2022 | Q2 | 100.0% | -2845.1% | 19.1% | -74.2% | -0.44 | 1.68 | -1018.8 |
| 31 Mar 2022 | Q1 | 100.0% | -2209.4% | 16.5% | -44.1% | -0.47 | 2.33 | -1523.5 |
| 31 Dec 2021 | Q4 | 100.0% | -2345.0% | 20.2% | -35.0% | -0.52 | 2.91 | -1275.4 |
| 30 Sept 2021 | Q3 | 100.0% | -2240.8% | 23.0% | -27.0% | -0.60 | 3.71 | -1334.7 |
| 30 Jun 2021 | Q2 | 100.0% | -1766.5% | 21.8% | -16.1% | -0.72 | 3.25 | -2671.1 |
| 31 Mar 2021 | Q1 | 100.0% | -1980.1% | 12.2% | -120.5% | -0.34 | 0.58 | -2196.0 |
| 31 Dec 2020 | Q4 | 100.0% | -1917.0% | 13.0% | -66.7% | -0.36 | 1.20 | -4398.2 |